Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18963373 | PROXIMAL-FEMUR INTRAOSSEOUS RELEASE DEVICE | November 2024 | March 2025 | Allow | 4 | 1 | 0 | No | No |
| 18850758 | MANUAL CONTROL HANDHELD PRESSURE-ADJUSTABLE IRRIGATION AND SUCTION ELECTROCOAGULATION CUTTER | September 2024 | March 2025 | Allow | 6 | 0 | 0 | No | No |
| 18393582 | OPHTHALMOLOGICAL SURGERY MICROSURGERY INSTRUMENTS AND METHODS OF USE IN PARS PLANA VITRECTOMY FOR INCREASING SURGICAL PRECISION AND REDUCING VITREORETINAL INSTRUMENT INSERTIONS AND REMOVALS AND RELATED TRAUMA | December 2023 | November 2024 | Abandon | 11 | 0 | 1 | No | No |
| 18238298 | Blood Control for a Catheter Insertion Device | August 2023 | May 2025 | Allow | 20 | 0 | 0 | No | No |
| 18178728 | CONTROLLED FLOW DRUG DELIVERY IMPLANTABLE DEVICE | March 2023 | September 2023 | Allow | 6 | 1 | 0 | Yes | No |
| 18000925 | SYRINGE INJECTOR WITH A FEEDBACK MECHANISM | December 2022 | January 2024 | Abandon | 13 | 1 | 0 | No | No |
| 17893577 | OPHTHALMOLOGICAL SURGERY MICROSURGERY INSTRUMENTS AND METHODS OF USE IN PARS PLANA VITRECTOMY FOR INCREASING SURGICAL PRECISION AND REDUCING VITREORETINAL INSTRUMENT INSERTIONS AND REMOVALS AND RELATED TRAUMA | August 2022 | January 2024 | Abandon | 17 | 1 | 1 | No | No |
| 17866621 | OCULAR SURGICAL WORK TIP ADAPTER | July 2022 | April 2025 | Allow | 33 | 2 | 0 | No | No |
| 17812397 | METHODS AND DEVICES FOR VASCULAR ACCESS | July 2022 | January 2023 | Allow | 6 | 1 | 0 | Yes | No |
| 17846416 | CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICE | June 2022 | April 2024 | Allow | 22 | 1 | 0 | No | No |
| 17838881 | INTRAOSSEOUS DEVICE HAVING RETRACTABLE MOTOR/STYLET ASSEMBLY AND AUTOMATIC STYLET POINT COVER UPON RETRACTION OPERATION | June 2022 | November 2024 | Abandon | 29 | 2 | 0 | No | No |
| 17826799 | SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODS | May 2022 | February 2024 | Allow | 21 | 1 | 0 | Yes | No |
| 17704589 | MEDICATION INJECTION SYSTEM | March 2022 | April 2024 | Allow | 25 | 1 | 0 | No | No |
| 17669899 | Devices and Methods for Delivering Fluid to a Nasal Cavity | February 2022 | December 2024 | Allow | 34 | 1 | 0 | No | No |
| 17564388 | CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICE | December 2021 | April 2022 | Allow | 4 | 0 | 0 | No | No |
| 17493570 | Transradial Sheath Support and Hemostasis Device and Method | October 2021 | April 2024 | Allow | 30 | 1 | 0 | No | No |
| 17474545 | Catheter Assembly With Angle Changing and Related Methods | September 2021 | May 2025 | Allow | 44 | 2 | 0 | No | No |
| 17469613 | Aspiration Apparatus for Intraosseous Access System | September 2021 | May 2025 | Allow | 44 | 2 | 1 | No | No |
| 17405996 | Catheter Assembly Including Transitioning Lumens | August 2021 | April 2025 | Allow | 44 | 4 | 0 | No | No |
| 17322942 | METHOD FOR MANUFACTURING NUCLEIC ACID FILM AND APPARATUS FOR INJECTING MEDICINE USING NUCLEIC ACID FILM | May 2021 | March 2025 | Allow | 46 | 1 | 0 | Yes | No |
| 17323348 | POLYMER SYSTEM FOR SECURING IMPLANTS IN SYRINGE NEEDLES | May 2021 | October 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17307630 | NEEDLELESS CONNECTOR WITH COMPRESSIBLE AND DEFLECTABLE VALVE | May 2021 | April 2024 | Allow | 35 | 1 | 1 | No | No |
| 17279415 | CONNECTOR | March 2021 | April 2024 | Allow | 37 | 1 | 0 | No | No |
| 17181808 | VIAL SUPPORTER FOR MEDICAMENT PUMP | February 2021 | February 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17164517 | DELIVERY DEVICE FOR BIOLOGIC MATERIAL | February 2021 | November 2024 | Abandon | 45 | 1 | 0 | No | No |
| 17147240 | RESPIRATORY CARE SYSTEM WITH ELECTRONIC INDICATOR | January 2021 | May 2025 | Allow | 52 | 2 | 0 | Yes | Yes |
| 17259606 | CATHETER | January 2021 | June 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17259774 | FLUID PRODUCT INJECTION DEVICE | January 2021 | January 2025 | Allow | 48 | 1 | 0 | No | No |
| 17259783 | FLUID INJECTION DEVICE | January 2021 | January 2025 | Allow | 48 | 1 | 0 | No | No |
| 17259227 | METHOD AND APPARATUS | January 2021 | November 2024 | Abandon | 46 | 1 | 1 | No | No |
| 17135571 | AGENT DELIVERY SYSTEMS AND METHODS OF USING THE SAME | December 2020 | May 2024 | Allow | 41 | 1 | 0 | No | No |
| 17131259 | COUPLING DEVICE | December 2020 | April 2023 | Abandon | 28 | 1 | 0 | No | No |
| 17127588 | FLUSH INSTRUMENT WITH BLOOD EXPOSURE PROTECTION AND RELATED METHODS | December 2020 | February 2024 | Allow | 37 | 1 | 1 | No | No |
| 17127151 | PERI-VASCULAR TISSUE ABLATION CATHETERS | December 2020 | April 2024 | Allow | 40 | 1 | 0 | No | No |
| 17123708 | AGENT DELIVERY DEVICE | December 2020 | March 2025 | Allow | 51 | 2 | 1 | No | No |
| 17116768 | MEDICAL DEVICE FOR TREATING A VEIN | December 2020 | October 2022 | Allow | 22 | 0 | 0 | No | No |
| 17085816 | SYSTEMS AND APPARATUS FOR DRIP RATE MEASUREMENT FOR MEDICAL FLUID ADMINISTRATION | October 2020 | October 2023 | Allow | 36 | 1 | 0 | No | No |
| 17032059 | DEVICE AND METHODOLOGY FOR PREPARING SKIN FOR SELF-INJECTION | September 2020 | April 2023 | Abandon | 31 | 1 | 0 | No | No |
| 17011676 | DEAD END CONTAINER AND CONTAINER ASSEMBLY WITH DEAD END CONTAINER | September 2020 | May 2025 | Allow | 56 | 4 | 0 | No | No |
| 16971432 | PERITONEAL DIALYSIS MACHINE | August 2020 | November 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16992243 | Drive mechanism | August 2020 | April 2024 | Allow | 44 | 4 | 0 | Yes | No |
| 16962739 | AUTOMATIC INJECTION SYSTEM | July 2020 | December 2021 | Allow | 17 | 1 | 0 | Yes | No |
| 16900792 | INFUSION SET | June 2020 | April 2023 | Allow | 34 | 1 | 1 | Yes | No |
| 16884802 | FLUID DELIVERY DEVICE WITH SENSOR | May 2020 | March 2023 | Allow | 34 | 1 | 0 | No | No |
| 16875377 | Catheter Device System and Method of Use | May 2020 | April 2024 | Allow | 47 | 5 | 0 | Yes | No |
| 16760351 | Apparatus and Method for Intracranial Drug Injection | April 2020 | June 2023 | Allow | 37 | 2 | 0 | No | No |
| 16802778 | Devices and Methods for Delivering Fluid to a Nasal Cavity | February 2020 | October 2021 | Allow | 19 | 1 | 0 | No | No |
| 16642568 | Methods and Devices for Use in Treatment of Plantar Fasciitis and Fat Grafting | February 2020 | October 2023 | Allow | 44 | 1 | 1 | Yes | No |
| 16798153 | ASPIRATION AND INJECTION DEVICE | February 2020 | September 2023 | Allow | 43 | 2 | 0 | Yes | No |
| 16788839 | SALIVA SOLUTION METERING APPARATUS WITH DELIVERY TUBE RETAINING MOUTHPIECE | February 2020 | April 2023 | Allow | 38 | 2 | 0 | No | No |
| 16787077 | TAKE-HOME DRUG DELIVERY SYSTEM | February 2020 | May 2025 | Allow | 60 | 6 | 0 | Yes | No |
| 16777248 | CATHETER SHEATH DEVICES AND METHODS OF OPERATING CATHETER SHEATH DEVICE | January 2020 | December 2021 | Allow | 22 | 1 | 0 | Yes | No |
| 16775749 | AUTOMATIC DRUG DELIVERY DEVICE | January 2020 | October 2022 | Allow | 33 | 1 | 0 | No | No |
| 16632822 | TIP FOR INTRA-TYMPANIC INJECTION | January 2020 | April 2023 | Allow | 38 | 2 | 0 | Yes | No |
| 16630656 | APPARATUS AND METHOD FOR OPENING AND CLOSING AN INFUSION TUBE CLAMP | January 2020 | April 2024 | Allow | 51 | 2 | 1 | Yes | No |
| 16729205 | LIQUID MEDICINE INJECTION DEVICE | December 2019 | April 2023 | Allow | 40 | 1 | 0 | No | No |
| 16722177 | Large Bore Enteral Connector | December 2019 | April 2024 | Allow | 52 | 3 | 0 | Yes | No |
| 16696844 | Blood Control for a Catheter Insertion Device | November 2019 | April 2023 | Allow | 41 | 1 | 0 | No | No |
| 16694267 | SYSTEMS AND METHODS FOR ENHANCING UPTAKE OF THERAPEUTIC AGENT FROM BLOODSTREAM INTO DISEASE SITE | November 2019 | April 2023 | Abandon | 41 | 1 | 0 | No | No |
| 16691579 | SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODS | November 2019 | October 2022 | Allow | 35 | 1 | 0 | No | No |
| 16690086 | DRUG DELIVERY DEVICE WITH DOSE KNOB CLUTCH | November 2019 | January 2024 | Allow | 49 | 2 | 0 | No | No |
| 16687664 | Systems and Methods Related to Syringes | November 2019 | January 2024 | Allow | 50 | 3 | 0 | Yes | No |
| 16613766 | SELF-RIGHTING SYSTEMS AND RELATED COMPONENTS AND METHODS | November 2019 | October 2021 | Allow | 23 | 2 | 0 | Yes | No |
| 16683126 | SYSTEM AND METHOD FOR MICRODOSE INJECTION | November 2019 | March 2022 | Allow | 29 | 1 | 0 | No | No |
| 16594390 | FLUID DELIVERY DEVICE WITH HYDROPHOBIC SURFACE | October 2019 | October 2022 | Allow | 36 | 1 | 0 | Yes | No |
| 16500608 | SYRINGE TYPE EJECTION DEVICE | October 2019 | January 2023 | Allow | 39 | 2 | 0 | No | No |
| 16586275 | SURFACE MODIFICATION METHOD AND GASKET FOR SYRINGE | September 2019 | January 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16566880 | ADAPTER FOR SINGLE-HANDED OPERATION OF SYRINGE DURING ASPIRATION OPERATION | September 2019 | October 2022 | Allow | 37 | 2 | 0 | Yes | No |
| 16564736 | Plunger for Syringes and Syringes | September 2019 | November 2024 | Allow | 60 | 3 | 0 | Yes | No |
| 16489243 | MIDLINE CATHETER PLACEMENT DEVICE | August 2019 | November 2021 | Allow | 27 | 1 | 0 | No | No |
| 16545953 | INTEGRATED PERIPHERAL INTRA-VENOUS CATHETER WITH IMPROVED EXTENSION TUBE PORT PROBE ACCESS | August 2019 | June 2023 | Allow | 46 | 2 | 0 | Yes | No |
| 16525477 | ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE | July 2019 | April 2022 | Allow | 33 | 1 | 0 | Yes | No |
| 16479510 | AUTO-INJECTOR DEVICE | July 2019 | March 2020 | Allow | 8 | 1 | 0 | Yes | No |
| 16473247 | STEERABLE CATHETER SUITABLE FOR LEFT-HAND OPERATION | June 2019 | September 2023 | Allow | 51 | 3 | 1 | No | No |
| 16447684 | CATHETER SECUREMENT, STABILIZATION, AND ANTI-MICROBIAL DEVICE | June 2019 | October 2022 | Allow | 40 | 4 | 0 | Yes | No |
| 16438857 | SEALING CONTAINER | June 2019 | October 2022 | Allow | 40 | 1 | 0 | No | No |
| 16466505 | NEEDLE SHIELD REMOVAL MECHANISM FOR INJECTION DEVICE | June 2019 | April 2022 | Allow | 34 | 3 | 0 | Yes | No |
| 16344430 | MEDICAMENT INJECTION DEVICE | April 2019 | February 2022 | Allow | 33 | 2 | 0 | Yes | No |
| 16376821 | PASSIVE SAFETY INTRAOSSEOUS DEVICE | April 2019 | June 2022 | Allow | 39 | 0 | 0 | No | No |
| 16358707 | INTRAOSSEOUS DEVICE HAVING RETRACTABLE MOTOR/STYLET ASSEMBLY AND AUTOMATIC STYLET POINT COVER UPON RETRACTION OPERATION | March 2019 | March 2022 | Allow | 36 | 1 | 0 | No | No |
| 16358714 | COMBINATION INTRAOSSEOUS DRILL AND FLASHLIGHT | March 2019 | July 2022 | Abandon | 40 | 0 | 1 | No | No |
| 16359093 | INTRAOSSEOUS DRILLING DEVICE WITH BARREL HAVING INTERNAL STYLET/MOTOR HOUSING WITH BARREL OPENING EXTENDER | March 2019 | December 2022 | Abandon | 45 | 1 | 0 | No | No |
| 16359314 | DISPOSABLE SINGLE-USE INTRAOSSEOUS DEVICE WITH BATTERY REMOVAL DOORS HAVING LIVING HINGE ON HANDLE | March 2019 | July 2022 | Abandon | 40 | 1 | 0 | No | No |
| 16359062 | FULLY DISPOSABLE SINGLE-USE PASSIVE SAFETY INTRAOSSEOUS DEVICE | March 2019 | July 2022 | Abandon | 40 | 1 | 0 | No | No |
| 16359080 | FOLDABLE, STOWABLE INTRAOSSEOUS DEVICE WITH AUTOMATIC POWER GENERATION WHEN OPENED | March 2019 | September 2022 | Abandon | 42 | 0 | 1 | No | No |
| 16359854 | INTRAOSSEOUS DEVICE HAVING INTEGRATED MOTOR AND STYLET | March 2019 | October 2022 | Abandon | 43 | 1 | 0 | No | No |
| 16359372 | CANNULA WITH RECESSED HUB STRUCTURE | March 2019 | July 2022 | Abandon | 40 | 1 | 0 | No | No |
| 16359868 | FOLDABLE, STOWABLE INTRAOSSEOUS DEVICE THAT STANDS ALONE ON FLAT SURFACE WHEN UNFOLDED | March 2019 | March 2023 | Abandon | 48 | 1 | 0 | No | No |
| 16326756 | LIQUID MEDICINE INJECTION DEVICE | February 2019 | September 2019 | Allow | 7 | 0 | 0 | Yes | No |
| 16192331 | SUTURING NEEDLE FOR INJECTING GOLD THREAD FOR USE OF HAIR LOSS TREATMENT | November 2018 | December 2019 | Allow | 13 | 2 | 0 | Yes | No |
| 16125767 | PASSIVE SAFETY INTRAOSSEOUS DEVICE | September 2018 | May 2022 | Abandon | 44 | 0 | 1 | No | No |
| 16075376 | TRANSDERMAL PERMEANT APPLICATION DEVICE | August 2018 | May 2022 | Allow | 45 | 1 | 1 | Yes | No |
| 16038967 | INTRAVENOUS CATHETER WITH PRESSURE ACTIVATED VALVE | July 2018 | May 2022 | Allow | 46 | 3 | 0 | No | No |
| 15777490 | IONTOPHORESIS DEVICE FOR DRUG DELIVERY AND METHOD FOR MANUFACTURING THE SAME | May 2018 | October 2022 | Allow | 53 | 2 | 0 | No | No |
| 15947626 | PERI-VASCULAR TISSUE ABLATION CATHETERS | April 2018 | May 2020 | Allow | 25 | 1 | 0 | No | No |
| 15945981 | SURGICAL APPARATUS AND SMOKE DISCHARGING SYSTEM | April 2018 | January 2022 | Abandon | 46 | 2 | 0 | Yes | No |
| 15766123 | SYRINGES WITH PLUNGER ROD DOSE CONTROL MECHANISM | April 2018 | January 2022 | Abandon | 46 | 0 | 1 | No | No |
| 15766231 | A POSITION DETERMINATION DEVICE FOR DETERMINING AND REGISTERING AN INJECTION LOCATION | April 2018 | September 2022 | Abandon | 53 | 2 | 0 | No | No |
| 15911478 | Drug Storage and Dispensing System for Pre-Filled Containers | March 2018 | September 2023 | Allow | 60 | 5 | 0 | No | No |
| 15909548 | HOLLOW NEEDLE FOR ACCESS IN NON-LINEAR PATH | March 2018 | May 2022 | Allow | 50 | 3 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner IGEL JR, MARK ALAN.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 57.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner IGEL JR, MARK ALAN works in Art Unit 3783 and has examined 179 patent applications in our dataset. With an allowance rate of 68.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 37 months.
Examiner IGEL JR, MARK ALAN's allowance rate of 68.2% places them in the 22% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by IGEL JR, MARK ALAN receive 1.83 office actions before reaching final disposition. This places the examiner in the 56% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by IGEL JR, MARK ALAN is 37 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +34.8% benefit to allowance rate for applications examined by IGEL JR, MARK ALAN. This interview benefit is in the 85% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 32.1% of applications are subsequently allowed. This success rate is in the 59% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 39.1% of cases where such amendments are filed. This entry rate is in the 52% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 76% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 85.7% of appeals filed. This is in the 77% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 60.0% are granted (fully or in part). This grant rate is in the 77% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.